A_DT
critical_JJ
role_NN
of_IN
the_DT
p75_NN
tumor_NN
necrosis_NN
factor_NN
receptor_NN
-LRB-_-LRB-
p75TNF-R_NN
-RRB-_-RRB-
in_IN
organ_NN
inflammation_NN
independent_JJ
of_IN
TNF_NN
,_,
lymphotoxin_NN
alpha_NN
,_,
or_CC
the_DT
p55TNF-R_NN
._.

Despite_IN
overwhelming_JJ
evidence_NN
that_IN
enhanced_VBN
production_NN
of_IN
the_DT
p75_NN
tumor_NN
necrosis_NN
factor_NN
receptor_NN
-LRB-_-LRB-
p75TNF-R_NN
-RRB-_-RRB-
accompanies_VBZ
development_NN
of_IN
specific_JJ
human_JJ
inflammatory_JJ
pathologies_NNS
such_JJ
as_IN
multi-organ_JJ
failure_NN
during_IN
sepsis_NN
,_,
inflammatory_JJ
liver_NN
disease_NN
,_,
pancreatitis_NN
,_,
respiratory_JJ
distress_NN
syndrome_NN
,_,
or_CC
AIDS_NN
,_,
the_DT
function_NN
of_IN
this_DT
receptor_NN
remains_VBZ
poorly_RB
defined_VBN
in_FW
vivo_FW
._.

We_PRP
show_VBP
here_RB
that_IN
at_IN
levels_NNS
relevant_JJ
to_TO
human_JJ
disease_NN
,_,
production_NN
of_IN
the_DT
human_JJ
p75TNF-R_NN
in_IN
transgenic_JJ
mice_NNS
results_VBZ
in_IN
a_DT
severe_JJ
inflammatory_JJ
syndrome_NN
involving_VBG
mainly_RB
the_DT
pancreas_NN
,_,
liver_NN
,_,
kidney_NN
,_,
and_CC
lung_NN
,_,
and_CC
characterized_VBN
by_IN
constitutively_RB
increased_VBN
NF-kappaB_NN
activity_NN
in_IN
the_DT
peripheral_JJ
blood_NN
mononuclear_JJ
cell_NN
compartment_NN
._.

This_DT
process_NN
is_VBZ
shown_VBN
to_TO
evolve_VB
independently_RB
of_IN
the_DT
presence_NN
of_IN
TNF_NN
,_,
lymphotoxin_NN
alpha_NN
,_,
or_CC
the_DT
p55TNF-R_NN
,_,
although_IN
coexpression_NN
of_IN
a_DT
human_JJ
TNF_NN
transgene_NN
accelerated_VBD
pathology_NN
._.

These_DT
results_NNS
establish_VBP
an_DT
independent_JJ
role_NN
for_IN
enhanced_VBN
p75TNF-R_NN
production_NN
in_IN
the_DT
pathogenesis_NN
of_IN
inflammatory_JJ
disease_NN
and_CC
implicate_VBP
the_DT
direct_JJ
involvement_NN
of_IN
this_DT
receptor_NN
in_IN
a_DT
wide_JJ
range_NN
of_IN
human_JJ
inflammatory_JJ
pathologies_NNS
._.

